(Q36527929)

14 August 2017

1 reference

title

Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham Study (English)

1 reference

14 August 2017

1

William B Kannel

1 reference

14 August 2017

2

Philip A Wolf

1 reference

14 August 2017

1 July 2006

1 reference

Current Atherosclerosis Reports

14 August 2017

1 reference

14 August 2017

8

1 reference

14 August 2017

317-323

1 reference

14 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-006-0010-3

14 August 2017

0 references

cites work

American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0010-3

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0010-3

Determinants of early recurrence of cerebral infarction. The Stroke Data Bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0010-3

Survival and recurrence following stroke. The Framingham study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0010-3

Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0010-3

Silent stroke in the NINCDS Stroke Data Bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0010-3

Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0010-3

Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0010-3

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0010-3

Multivariate prediction of coronary heart disease in the Western Collaborative Group Study compared to the findings of the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0010-3

Intermittent claudication. A risk profile from The Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0010-3

Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0010-3

Prevalence of silent stroke in patients presenting with initial stroke: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0010-3

Probability of stroke: a risk profile from the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0010-3

Silent brain infarcts and the risk of dementia and cognitive decline.

21 January 2018

1 reference

12 December 2020

Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study

1 reference

12 December 2020

The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study.

1 reference

12 December 2020

Stroke mortality trends. An international perspective.

1 reference

12 December 2020

Prevalence of peripheral arterial disease: persistence of excess risk in former smokers

1 reference

12 December 2020

Silent brain infarcts in patients with manifest vascular disease

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Cigarette smoking as a risk factor for stroke. The Framingham Study.

1 reference

12 December 2020

Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study

1 reference

12 December 2020

Metabolic syndrome: a clinical and molecular perspective

1 reference

12 December 2020

Asymptomatic carotid bruit and risk of stroke. The Framingham study

1 reference

12 December 2020

Medical treatment of peripheral arterial disease and claudication

1 reference

12 December 2020

Manifestations of coronary disease predisposing to stroke. The Framingham study

1 reference

12 December 2020

Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories

1 reference

12 December 2020

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

12 December 2020

Syndrome X: 6 years later

1 reference

12 December 2020

Mitral annular calcification and the risk of stroke in an elderly cohort

1 reference

12 December 2020

Cholesterol and carotid atherosclerosis in older persons: the Framingham Study

1 reference

12 December 2020

Management of risk in peripheral artery disease: recent therapeutic advances

1 reference

12 December 2020

Temporal trends in the incidence of intermittent claudication from 1950 to 1999.

1 reference

12 December 2020

Metabolic Syndrome Compared With Type 2 Diabetes Mellitus as a Risk Factor for Stroke

1 reference

12 December 2020

10.1007/S11883-006-0010-3

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16822398